Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Inventory | 29.23%120.59M | 26.91%111.62M | -8.81%93.31M | -27.32%87.95M | -26.35%102.33M | -8.22%121.01M | 2.39%138.93M | 0.24%131.85M | -5.06%135.69M | -35.14%131.54M |
| Accounts receivable | -7.93%76.58M | -24.19%79.92M | -11.94%83.17M | 21.94%105.42M | 3.23%94.45M | -39.84%86.46M | -43.34%91.49M | -10.85%143.71M | 16.93%161.48M | 10.01%161.21M |
| Advance deposits and other receivables | -4.20%368.38M | 0.34%378.38M | -18.24%384.52M | -64.76%377.1M | -19.74%470.28M | 83.67%1.07B | -2.31%585.91M | -11.09%582.67M | -13.30%599.78M | -41.45%655.37M |
| Withholding and tax receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -61.81%569K | ---- |
| Cash and equivalents | -42.53%41.72M | 13.66%89.36M | -88.40%72.59M | -71.43%78.62M | 628.95%625.69M | 606.77%275.14M | 120.02%85.84M | -39.70%38.93M | -35.92%39.01M | -0.21%64.56M |
| Financial assets at fair value-current assets | ---- | ---- | -42.63%144K | 13,095.62%60.3M | -50.00%251K | -48.07%457K | --502K | --880K | ---- | ---- |
| Total current assets | -4.18%607.27M | -7.07%659.27M | -50.99%633.73M | -54.33%709.39M | 43.24%1.29B | 72.96%1.55B | -3.62%902.67M | -11.32%898.04M | -9.53%936.53M | -35.57%1.01B |
| Non-current assets | ||||||||||
| Property, plant and equipment | 139.32%248.4M | 177.53%249.56M | 42.59%103.79M | 34.74%89.92M | 21.78%72.79M | 7.17%66.74M | -21.64%59.77M | -24.97%62.27M | -18.77%76.28M | -20.78%82.99M |
| Investment property | -0.11%36.92M | -0.11%36.92M | -5.16%36.96M | -5.16%36.96M | -17.36%38.98M | -17.36%38.98M | 0.18%47.16M | 0.18%47.16M | -3.21%47.08M | -3.21%47.08M |
| Advance payment | -27.35%325.77M | -33.15%292.14M | --448.4M | --437M | ---- | ---- | ---- | --17.92M | ---- | ---- |
| Associated company interest | -20.98%43.3M | 175.26%41.29M | --54.8M | --15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial assets at fair value-non-current assets | -15.81%55.31M | 491.42%75.09M | --65.7M | --12.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%2.66M | 0.00%2.66M |
| Deferred tax assets | 300.68%13.03M | 323.87%13.03M | 0.03%3.25M | -15.13%3.08M | 0.00%3.25M | -1.60%3.62M | -81.96%3.25M | -78.07%3.68M | -59.68%18.02M | -60.84%16.79M |
| Total non-current assets | -0.70%867.28M | 11.00%855.17M | 500.63%873.4M | 449.63%770.39M | 2.81%145.41M | -2.98%140.17M | -45.42%141.45M | -48.14%144.47M | -20.40%259.17M | -23.77%278.56M |
| Total assets | -2.16%1.47B | 2.34%1.51B | 4.78%1.51B | -12.62%1.48B | 37.76%1.44B | 62.44%1.69B | -12.68%1.04B | -19.26%1.04B | -12.13%1.2B | -33.35%1.29B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | 31.67%254.6M | 0.95%231.13M | -0.10%193.36M | 0.79%228.95M | -20.95%193.55M | -7.85%227.15M | -8.72%244.84M | -13.06%246.49M | 6.39%268.23M | 18.66%283.51M |
| Tax payable | 51.42%9.19M | 291.88%15.98M | 24.31%6.07M | -34.73%4.08M | 14.06%4.88M | 70.33%6.25M | 4.75%4.28M | 10.22%3.67M | 2.41%4.09M | -18.97%3.33M |
| Amounts payable to associated parties-current liabilities | ---- | ---- | -48.59%13M | ---- | --25.29M | ---- | ---- | ---- | ---- | ---- |
| Other payables and accrued expenses | 2.06%204.41M | 4.10%200.97M | 4.31%200.29M | 3.11%193.06M | 9.65%192.02M | 14.23%187.24M | -3.53%175.12M | -18.58%163.9M | 6.78%181.52M | 10.74%201.31M |
| Bank loans and overdrafts | -5.06%244.52M | 10.12%248.48M | 7.21%257.54M | -16.17%225.63M | -10.53%240.22M | 1.94%269.15M | -5.91%268.5M | -7.87%264.04M | -9.33%285.38M | -41.51%286.6M |
| Financial lease liabilities-current liabilities | 44.00%2.53M | -11.77%3M | 26.40%1.76M | 36.25%3.4M | -44.27%1.39M | -10.80%2.49M | -74.34%2.49M | -75.09%2.8M | -19.17%9.72M | -8.96%11.22M |
| Total current liabilities | 5.63%739.43M | 6.24%722.64M | -0.21%700.03M | -27.91%680.18M | -5.72%701.5M | 30.09%943.51M | -7.94%744.05M | -15.16%725.3M | -1.53%808.23M | -15.28%854.92M |
| Net current assets | -99.33%-132.16M | -316.95%-63.37M | -111.21%-66.3M | -95.21%29.21M | 272.91%591.49M | 253.00%609.76M | 23.63%158.62M | 9.50%172.74M | -40.14%128.3M | -71.96%157.75M |
| Total assets less current liabilities | -8.92%735.12M | -0.98%791.79M | 9.53%807.1M | 6.62%799.6M | 145.59%736.91M | 136.42%749.93M | -22.56%300.06M | -27.30%317.21M | -28.24%387.46M | -52.99%436.31M |
| Non-current liabilities | ||||||||||
| Long-term bank loan | -19.00%55.81M | -27.80%56.66M | 361.45%68.89M | 112.10%78.48M | -86.82%14.93M | -66.46%37M | 111.24%113.25M | 103.75%110.33M | --53.61M | --54.15M |
| Payments payable to related parties-non-current liabilities | ---- | ---- | ---- | ---- | --17.39M | ---- | ---- | ---- | ---- | ---- |
| Financial lease liabilities-non-current liabilities | 69.46%2.49M | 121.03%3.3M | --1.47M | 857.05%1.49M | ---- | -94.00%156K | -98.57%1.39M | -97.37%2.6M | -4.50%97.15M | -6.43%98.84M |
| Deferred tax liability | -0.06%9.48M | -0.06%9.48M | -3.09%9.49M | -3.09%9.49M | -1.53%9.79M | -0.32%9.79M | -5.01%9.94M | -6.16%9.82M | -3.50%10.47M | -3.59%10.47M |
| Deferred income-non-current liabilities | --66.4M | --66.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non-current liabilities | 68.03%134.17M | 51.85%135.84M | 89.61%79.85M | 90.55%89.46M | -66.20%42.11M | -61.75%46.95M | -22.73%124.58M | -24.91%122.75M | -3.90%161.22M | 40.32%163.46M |
| Total liabilities | 12.02%873.6M | 11.54%858.48M | 4.88%779.88M | -22.29%769.64M | -14.39%743.62M | 16.79%990.46M | -10.40%868.64M | -16.73%848.05M | -1.93%969.45M | -9.53%1.02B |
| Total assets less total liabilities | -17.37%600.95M | -7.63%655.95M | 4.67%727.25M | 1.02%710.15M | 295.94%694.8M | 261.50%702.98M | -22.44%175.48M | -28.73%194.46M | -39.21%226.24M | -66.38%272.86M |
| Total equity and non-current liabilities | -8.92%735.12M | -0.98%791.79M | 9.53%807.1M | 6.62%799.6M | 145.59%736.91M | 136.42%749.93M | -22.56%300.06M | -27.30%317.21M | -28.24%387.46M | -52.99%436.31M |
| Equity | ||||||||||
| Share capital | 0.00%1.49B | 0.00%1.49B | 0.00%1.49B | 0.00%1.49B | 167.97%1.49B | 167.97%1.49B | 0.00%556.29M | 0.00%556.29M | 0.00%556.29M | 0.00%556.29M |
| Reserve | -13.13%-1.04B | -10.64%-990.6M | -13.71%-923.02M | -11.42%-895.33M | -105.12%-811.71M | -113.44%-803.57M | -20.68%-395.72M | -32.53%-376.49M | -68.89%-327.9M | -218.56%-284.08M |
| Shareholders' Equity | -21.36%446.45M | -16.00%500.1M | -16.39%567.69M | -13.35%595.38M | 322.88%678.99M | 282.17%687.14M | -29.70%160.57M | -33.95%179.8M | -36.93%228.39M | -65.80%272.2M |
| Non-controlling interest | -3.17%154.5M | 35.79%155.85M | 909.62%159.56M | 624.36%114.77M | 5.96%15.8M | 8.06%15.84M | 794.69%14.92M | 2,148.77%14.66M | -121.37%-2.15M | -95.85%652K |
| Total equity | -17.37%600.95M | -7.63%655.95M | 4.67%727.25M | 1.02%710.15M | 295.94%694.8M | 261.50%702.98M | -22.44%175.48M | -28.73%194.46M | -39.21%226.24M | -66.38%272.86M |
| Total equity and total liabilities | -2.16%1.47B | 2.34%1.51B | 4.78%1.51B | -12.62%1.48B | 37.76%1.44B | 62.44%1.69B | -12.68%1.04B | -19.26%1.04B | -12.13%1.2B | -33.35%1.29B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants | -- | Guowei Certified Public Accountants | -- | Guowei Certified Public Accountants | -- | Guowei Certified Public Accountants | -- | National Health Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.